PortfoliosLab logoPortfoliosLab logo
HLS.TO vs. GDXU
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

HLS.TO vs. GDXU - Performance Comparison

The chart below illustrates the hypothetical performance of a CA$10,000 investment in HLS Therapeutics Inc. (HLS.TO) and MicroSectors Gold Miners 3X Leveraged ETNs due June 29, 2040 (GDXU). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

HLS.TO is traded in CAD, while GDXU is traded in USD. To make them comparable, the GDXU values have been converted to CAD using the latest available exchange rates.

Returns By Period

In the year-to-date period, HLS.TO achieves a -14.73% return, which is significantly higher than GDXU's -71.62% return.


HLS.TO

1D
0.00%
1M
-5.30%
6M
-12.92%
YTD
-14.73%
1Y
-16.12%
3Y*
-12.57%
5Y*
-24.57%
10Y*
ALL TIME*
-11.14%

GDXU

1D
-2.44%
1M
-41.24%
6M
-80.24%
YTD
-71.62%
1Y
2.09%
3Y*
20.20%
5Y*
-12.76%
10Y*
ALL TIME*
-19.18%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HLS.TO vs. GDXU - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
HLS.TO
HLS Therapeutics Inc.
-14.73%22.65%-0.51%-59.25%-33.41%-15.74%2.39%
GDXU
MicroSectors Gold Miners 3X Leveraged ETNs due June 29, 2040
-71.62%755.54%-11.71%-23.23%-60.46%-54.96%2.98%

Correlation

The correlation between HLS.TO and GDXU is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.01

Correlation (3Y)
Calculated over the trailing 3-year period

0.00

Correlation (5Y)
Calculated over the trailing 5-year period

0.09

Correlation (All Time)
Calculated using the full available price history since Dec 3, 2020

0.08

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HLS.TO vs. GDXU — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HLS.TO
HLS.TO Risk / Return Rank: 1919
Overall Rank
HLS.TO Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
HLS.TO Sortino Ratio Rank: 1616
Sortino Ratio Rank
HLS.TO Omega Ratio Rank: 1515
Omega Ratio Rank
HLS.TO Calmar Ratio Rank: 2424
Calmar Ratio Rank
HLS.TO Martin Ratio Rank: 2525
Martin Ratio Rank

GDXU
GDXU Risk / Return Rank: 1616
Overall Rank
GDXU Sharpe Ratio Rank: 1111
Sharpe Ratio Rank
GDXU Sortino Ratio Rank: 2424
Sortino Ratio Rank
GDXU Omega Ratio Rank: 2525
Omega Ratio Rank
GDXU Calmar Ratio Rank: 1010
Calmar Ratio Rank
GDXU Martin Ratio Rank: 1010
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HLS.TO vs. GDXU - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for HLS Therapeutics Inc. (HLS.TO) and MicroSectors Gold Miners 3X Leveraged ETNs due June 29, 2040 (GDXU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HLS.TOGDXUDifference
Sharpe ratioReturn per unit of total volatility

-0.71

Sortino ratioReturn per unit of downside risk

-1.92

Omega ratioGain probability vs. loss probability

0.88

1.14

-0.26

Calmar ratioReturn relative to maximum drawdown

-0.57

0.02

-0.60

Martin ratioReturn relative to average drawdown

-0.95

0.05

-1.00

HLS.TO vs. GDXU - Sharpe Ratio Comparison

The current HLS.TO Sharpe Ratio is -0.70, which is lower than the GDXU Sharpe Ratio of 0.01. The chart below compares the historical Sharpe Ratios of HLS.TO and GDXU, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HLS.TO vs. GDXU - Drawdown Comparison

The maximum HLS.TO drawdown since its inception was -87.56%, smaller than the maximum GDXU drawdown of -94.06%. Use the drawdown chart below to compare losses from any high point for HLS.TO and GDXU.


Loading charts...

Drawdown Indicators


HLS.TOGDXUDifference

Max Drawdown

Largest peak-to-trough decline

-87.56%

-94.06%

+6.50%

Max Drawdown (1Y)

Largest decline over 1 year

-28.15%

-86.73%

+58.58%

Max Drawdown (3Y)

Largest decline over 3 years

-52.97%

-86.73%

+33.76%

Max Drawdown (5Y)

Largest decline over 5 years

-84.66%

-90.63%

+5.97%

Current Drawdown

Current decline from peak

-83.02%

-86.73%

+3.71%

Average Drawdown

Average peak-to-trough decline

-49.37%

-69.30%

+19.93%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.93%

45.70%

-28.77%

Volatility

HLS.TO vs. GDXU - Volatility Comparison

The current volatility for HLS Therapeutics Inc. (HLS.TO) is 9.15%, while MicroSectors Gold Miners 3X Leveraged ETNs due June 29, 2040 (GDXU) has a volatility of 34.78%. This indicates that HLS.TO experiences smaller price fluctuations and is considered to be less risky than GDXU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HLS.TOGDXUDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.15%

34.78%

-25.63%

Volatility (6M)

Calculated over the trailing 6-month period

14.36%

126.11%

-111.75%

Volatility (1Y)

Calculated over the trailing 1-year period

23.26%

146.24%

-122.98%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

42.88%

112.96%

-70.08%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

46.35%

111.38%

-65.03%

Dividends

HLS.TO vs. GDXU - Dividend Comparison

Neither HLS.TO nor GDXU has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018
GDXU
MicroSectors Gold Miners 3X Leveraged ETNs due June 29, 2040
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
HLS.TO
HLS Therapeutics Inc.
0.00%0.00%0.00%2.53%2.03%1.33%1.11%0.78%0.34%

Frequently Asked Questions


HLS.TO and GDXU have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for HLS.TO and GDXU

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer